S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Modern Day Options Trading For Beginners! (Ad)pixel
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
Modern Day Options Trading For Beginners! (Ad)pixel
Travel disruption hits Germany on eve of transport strike
Berlin climate proposal fails to get enough yes votes to win
The gold catalyst we’ve waited for (Ad)
Adele extends Las Vegas residency, plans concert film
Turkmenistan votes for new, opposition-free parliament
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Modern Day Options Trading For Beginners! (Ad)pixel
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
Modern Day Options Trading For Beginners! (Ad)pixel
Travel disruption hits Germany on eve of transport strike
Berlin climate proposal fails to get enough yes votes to win
The gold catalyst we’ve waited for (Ad)
Adele extends Las Vegas residency, plans concert film
Turkmenistan votes for new, opposition-free parliament
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Modern Day Options Trading For Beginners! (Ad)pixel
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
Modern Day Options Trading For Beginners! (Ad)pixel
Travel disruption hits Germany on eve of transport strike
Berlin climate proposal fails to get enough yes votes to win
The gold catalyst we’ve waited for (Ad)
Adele extends Las Vegas residency, plans concert film
Turkmenistan votes for new, opposition-free parliament
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Modern Day Options Trading For Beginners! (Ad)pixel
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
Modern Day Options Trading For Beginners! (Ad)pixel
Travel disruption hits Germany on eve of transport strike
Berlin climate proposal fails to get enough yes votes to win
The gold catalyst we’ve waited for (Ad)
Adele extends Las Vegas residency, plans concert film
Turkmenistan votes for new, opposition-free parliament
NASDAQ:JYNT

Joint - JYNT Stock Forecast, Price & News

$16.39
-0.03 (-0.18%)
(As of 03/24/2023 12:00 AM ET)
Add
Compare
Today's Range
$15.87
$16.40
50-Day Range
$14.92
$19.56
52-Week Range
$12.85
$37.52
Volume
74,472 shs
Average Volume
123,777 shs
Market Capitalization
$238.15 million
P/E Ratio
204.88
Dividend Yield
N/A
Price Target
$32.83

Joint MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
100.3% Upside
$32.83 Price Target
Short Interest
Bearish
7.50% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.05mentions of Joint in the last 14 days
Based on 2 Articles This Week
Insider Trading
Acquiring Shares
$542,560 Bought Last Quarter
Proj. Earnings Growth
100.00%
From $0.12 to $0.24 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.11 out of 5 stars

Medical Sector

493rd out of 1,005 stocks

Patent Owners & Lessors Industry

4th out of 7 stocks


JYNT stock logo

About Joint (NASDAQ:JYNT) Stock

The Joint Corp. engages in the development, ownership, operation, support, and management of chiropractic clinics. It operates through two segments: Corporate Clinics and Franchise Operations. The Corporate Clinics segment consists of the operating activities of the company-owned or managed clinics. The Franchise Operations segment includes the operating activities of the franchise business unit. The Joint was founded by Fred Gerretzen, Charles Barnwell, John Leonesio, Todd Welker, Barbara Holland, Steven P. Colmar, Craig P. Colmar, and Richard Rees on March 10, 2010 and is headquartered in Scottsdale, AZ.

Receive JYNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Joint and its competitors with MarketBeat's FREE daily newsletter.

JYNT Stock News Headlines

The gold catalyst we’ve waited for
If you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.
The Joint Corp. (JYNT) Misses Q4 Earnings Estimates
The gold catalyst we’ve waited for
If you thought the SVB meltdown was bad… watch out. Because even bigger red flag just appeared. This signal proves that a recession is likely right around the corner. It will take most by surprise. Stocks will crash. Millions will go jobless, and lose their homes. But there is ONE important step you should take today to make sure you come out the other side OK.
The Joint Corp. Reports 2022 Operating Metrics
See More Headlines
Receive JYNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Joint and its competitors with MarketBeat's FREE daily newsletter.

JYNT Company Calendar

Last Earnings
11/04/2021
Today
3/26/2023
Next Earnings (Estimated)
5/04/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Patent owners & lessors
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:JYNT
Employees
316
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$32.83
High Stock Price Forecast
$50.00
Low Stock Price Forecast
$15.00
Forecasted Upside/Downside
+100.3%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

Net Income
$1.18 million
Pretax Margin
1.91%

Debt

Sales & Book Value

Annual Sales
$101.91 million
Cash Flow
$0.61 per share
Book Value
$2.23 per share

Miscellaneous

Free Float
14,021,000
Market Cap
$238.15 million
Optionable
Not Optionable
Beta
1.35

Key Executives

  • Peter D. Holt
    President, Chief Executive Officer & Director
  • Jorge Armenteros
    Senior Vice President-Operations
  • Jacob SingletonJacob Singleton
    Chief Financial Officer & Controller
  • Charles Nelles
    Chief Technology Officer
  • Steve Knauf
    Vice President-Chiropractic & Compliance













JYNT Stock - Frequently Asked Questions

Should I buy or sell Joint stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Joint in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" JYNT shares.
View JYNT analyst ratings
or view top-rated stocks.

What is Joint's stock price forecast for 2023?

4 analysts have issued 12 month target prices for Joint's shares. Their JYNT share price forecasts range from $15.00 to $50.00. On average, they anticipate the company's share price to reach $32.83 in the next year. This suggests a possible upside of 100.3% from the stock's current price.
View analysts price targets for JYNT
or view top-rated stocks among Wall Street analysts.

How have JYNT shares performed in 2023?

Joint's stock was trading at $13.98 at the start of the year. Since then, JYNT stock has increased by 17.2% and is now trading at $16.39.
View the best growth stocks for 2023 here
.

When is Joint's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 4th 2023.
View our JYNT earnings forecast
.

How were Joint's earnings last quarter?

The Joint Corp. (NASDAQ:JYNT) announced its quarterly earnings data on Thursday, November, 4th. The company reported $0.13 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.04 by $0.09. The company earned $20.99 million during the quarter, compared to the consensus estimate of $19.48 million. Joint had a trailing twelve-month return on equity of 3.79% and a net margin of 1.15%. During the same period in the prior year, the company earned $0.11 earnings per share.

What guidance has Joint issued on next quarter's earnings?

Joint updated its FY 2023 earnings guidance on Thursday, March, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $123.00 million-$128.00 million, compared to the consensus revenue estimate of $121.34 million.

What is Peter D. Holt's approval rating as Joint's CEO?

87 employees have rated Joint Chief Executive Officer Peter D. Holt on Glassdoor.com. Peter D. Holt has an approval rating of 59% among the company's employees. This puts Peter D. Holt in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Joint own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Joint investors own include Aurora Cannabis (ACB), Advanced Micro Devices (AMD), Raytheon Technologies (RTX), Salesforce (CRM), Mastercard (MA), Starbucks (SBUX), Twitter (TWTR), Viking Therapeutics (VKTX), AbbVie (ABBV) and Adobe (ADBE).

When did Joint IPO?

(JYNT) raised $20 million in an initial public offering on Tuesday, November 11th 2014. The company issued 3,000,000 shares at a price of $6.50 per share. Roth Capital Partners and Feltl and Company acted as the underwriters for the IPO and Sanders Morris Harris was co-manager.

What is Joint's stock symbol?

Joint trades on the NASDAQ under the ticker symbol "JYNT."

Who are Joint's major shareholders?

Joint's stock is owned by many different institutional and retail investors. Top institutional investors include Bandera Partners LLC (17.41%), Millennium Management LLC (3.87%), Morgan Stanley (3.43%), Skylands Capital LLC (3.07%), Geode Capital Management LLC (1.80%) and Two Sigma Investments LP (1.24%). Insiders that own company stock include Bandera Partners Llc, Glenn J Krevlin, Jake Singleton, James H Amos Jr, Matthew E Rubel, Matthew E Rubel, Peter D Holt and Ronald V Davella.
View institutional ownership trends
.

How do I buy shares of Joint?

Shares of JYNT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Joint's stock price today?

One share of JYNT stock can currently be purchased for approximately $16.39.

How much money does Joint make?

Joint (NASDAQ:JYNT) has a market capitalization of $238.15 million and generates $101.91 million in revenue each year. The company earns $1.18 million in net income (profit) each year or $0.08 on an earnings per share basis.

How many employees does Joint have?

The company employs 316 workers across the globe.

How can I contact Joint?

Joint's mailing address is 16767 N PERIMETER DRIVE SUITE 240, SCOTTSDALE AZ, 85260. The official website for the company is www.thejoint.com. The company can be reached via phone at (480) 245-5960, via email at thejoint@lhai.com, or via fax at 480-513-7989.

This page (NASDAQ:JYNT) was last updated on 3/26/2023 by MarketBeat.com Staff